PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Pharmaceutical and biotechnology companies - • Market size and forecast 2018-2023 • Hospitals and clinical testing laboratories - • Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Technological advances • Rise in industry-related developments • Initiatives to create awareness of and provide training in cell • sorting technology PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Becton, Dickinson and Co. • Bio-Rad Laboratories Inc. • Cytonome/St. LLC • Danaher Corp. • Miltenyi Biotec GmbH • On-Chip Biotechnologies Co. Ltd. • pluriSelect Life Science UG & Co. KG • Sony Corp. • Sysmex Corp. • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Vendor offerings Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: End-user - Market share 2018-2023 (%) Exhibit 19: Comparison by end-user Exhibit 20: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%) Exhibit 22: Hospitals and clinical testing laboratories - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Hospitals and clinical testing laboratories - Year-over-year growth 2019-2023 (%) Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Others - Year-over-year growth 2019-2023 (%) Exhibit 26: Market opportunity by end-user Exhibit 27: Customer landscape Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 31: North America - Year-over-year growth 2019-2023 (%) Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Asia - Year-over-year growth 2019-2023 (%) Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 37: ROW - Year-over-year growth 2019-2023 (%) Exhibit 38: Key leading countries Exhibit 39: Market opportunity Exhibit 40: Impact of drivers and challenges Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Becton, Dickinson and Co. - Vendor overview Exhibit 47: Becton, Dickinson and Co. - Business segments Exhibit 48: Becton, Dickinson and Co. - Organizational developments Exhibit 49: Becton, Dickinson and Co. - Geographic focus Exhibit 50: Becton, Dickinson and Co. - Segment focus Exhibit 51: Becton, Dickinson and Co. - Key offerings Exhibit 52: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 53: Bio-Rad Laboratories Inc. - Business segments Exhibit 54: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 55: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 56: Bio-Rad Laboratories Inc. - Segment focus Exhibit 57: Bio-Rad Laboratories Inc. - Key offerings Exhibit 58: Cytonome/St. LLC - Vendor overview Exhibit 59: Cytonome/St. LLC - Product segments Exhibit 60: Cytonome/St. LLC - Organizational developments Exhibit 61: Cytonome/St. LLC - Key offerings Exhibit 62: Danaher Corp. - Vendor overview Exhibit 63: Danaher Corp. - Business segments Exhibit 64: Danaher Corp. - Organizational developments Exhibit 65: Danaher Corp. - Geographic focus Exhibit 66: Danaher Corp. - Segment focus Exhibit 67: Danaher Corp. - Key offerings Exhibit 68: Miltenyi Biotec GmbH - Vendor overview Exhibit 69: Miltenyi Biotec GmbH - Product segments Exhibit 70: Miltenyi Biotec GmbH - Organizational developments Exhibit 71: Miltenyi Biotec GmbH - Key offerings Exhibit 72: On-Chip Biotechnologies Co. Ltd. - Vendor overview Exhibit 73: On-Chip Biotechnologies Co. Ltd. - Product segments Exhibit 74: On-Chip Biotechnologies Co. Ltd. - Key offerings Exhibit 75: pluriSelect Life Science UG & Co. KG - Vendor overview Exhibit 76: pluriSelect Life Science UG & Co. KG - Product segments Exhibit 77: pluriSelect Life Science UG & Co. KG - Key offerings Exhibit 78: Sony Corp. - Vendor overview Exhibit 79: Sony Corp. - Business segments Exhibit 80: Sony Corp. - Organizational developments Exhibit 81: Sony Corp. - Geographic focus Exhibit 82: Sony Corp. - Segment focus Exhibit 83: Sony Corp. - Key offerings Exhibit 84: Sysmex Corp. - Vendor overview Exhibit 85: Sysmex Corp. - Business segments Exhibit 86: Sysmex Corp. - Organizational developments Exhibit 87: Sysmex Corp. - Segment focus Exhibit 88: Sysmex Corp. - Key offerings Exhibit 89: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 90: Thermo Fisher Scientific Inc. - Business segments Exhibit 91: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 92: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 93: Thermo Fisher Scientific Inc. - Segment focus Exhibit 94: Thermo Fisher Scientific Inc. - Key offerings Exhibit 95: Validation techniques employed for market sizing Exhibit 96: Definition of market positioning of vendors

Becton, Dickinson, and Co., Bio-Rad Laboratories Inc., Cytonome/St. LLC, Danaher Corp., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co. Ltd., pluriSelect Life Science UG & Co. KG, Sony Corp., Sysmex Corp., and Thermo Fisher Scientific Inc.